'%2F%3E%3Cpath%20d%3D'M11%205H21M13.5%205V11.6A8.5%208.5%200%201%200%2018.5%2011.6V5'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'3.4'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Cpath%20d%3D'M10.6%2019.6L13.9%2021.8L17.6%2018.4L21.4%2020.4'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'2.6'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Ccircle%20cx%3D'17.6'%20cy%3D'18.4'%20r%3D'2.6'%20fill%3D'%23fff'%2F%3E%3C%2Fsvg%3E){kind=small}
Fermenta Biotech Limited
FERMENTA (NSE) · FERMENTA (BSE 506414) · ISIN INE225B01021 · Pharmaceuticals · Est. 1951 · listed 2026 · website
Not on any surveillance list
In Q1 FY27 (quarter to 30 June 2026, standalone), revenue was ₹111.84 cr and profit after tax ₹14.99 cr.
Next: Board meeting: financial results on 5 November 2026.
Open the full company file Every section, filings and your notes, in the app.
Quarterly results
| Quarter | Revenue | Profit after tax | EPS (₹) | Filed |
|---|---|---|---|---|
| Q1 FY27 standalone | ₹111.84 cr | ₹14.99 cr | 5.13 | 11 Aug 2026 |
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹422.82 cr | ₹108.89 cr | ₹652.36 cr |
| 30 Sep 2025 standalone | ₹402.52 cr | ₹106.88 cr | ₹654.39 cr |
| 31 Mar 2025 standalone | ₹379.95 cr | ₹109.4 cr | ₹622.47 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 60.12% | 1.05% | 0.00% | 37.49% |
Latest filings
- Fermenta Biotech Limited has informed the Exchange about Investor Presentation 11 August 2026 · NSE
- Fermenta Biotech Limited has informed the Exchange regarding a press release dated August 11, 2026, titled "Press release regarding unaudited financial results of Q1FY27.". 11 August 2026 · NSE
- Fermenta Biotech Limited has submitted to the Exchange, the unaudited financial results (standalone and consolidated) for the quarter ended Jun 30, 2026. 11 August 2026 · NSE
Other companies in Pharmaceuticals
- Lupin Limited
- Sun Pharmaceutical Industries Limited
- Cipla Limited
- Dr. Reddy's Laboratories Limited
- Torrent Pharmaceuticals Limited
- Zydus Lifesciences Limited
- Aurobindo Pharma Limited
- Divi's Laboratories Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.